QXO, Inc.
QXO
$10.34
-6.17%
QXO, Inc. is a North American distributor of building products — roofing, insulation, wallboard, lumber, and related installation services — operating in the roughly $800 billion building products distribution industry, with product sales of approximately $3.93 billion and service revenue of roughly $966 million in the latest quarter. The company is a roll-up platform built under serial acquirer Brad Jacobs, positioning itself as a consolidator of a highly fragmented, low-margin distribution sector rather than an organic-growth story, with a stated ambition of reaching nearly $50 billion in annual revenue within a decade. The investor narrative is dominated by the transformative ~$17 billion acquisition of TopBuild, which dramatically expanded scale and diversification but also introduced significant integration risk, dilution concerns, and a sharp increase in leverage — themes echoed in recent coverage questioning whether the deal creates value or destroys it. Sentiment has soured materially through 2026 as the stock has de-rated on acquisition-related dilution, negative free cash flow, and the market's skepticism about the pace and profitability of the roll-up strategy, even as sell-side analysts remain overwhelmingly constructive.…
QXO
QXO, Inc.
$10.34
Related headlines
Investment Opinion: Should I buy QXO Today?
Rating: Hold (speculative, high-risk). The core thesis is that QXO is a genuine scale transformation — $4.895 billion of quarterly revenue, +79.42% YoY, gross margin up from 14.17% to 28.19% in two quarters — but the market is not yet being paid for the execution risk, with trailing free cash flow of -$97.8 million, interest coverage of roughly 0.012x, and a 51.55x EV/EBITDA multiple that already discounts a successful TopBuild integration. The 19 Buy / 1 Hold / 0 Sell consensus with a $23.00 average target (+107% from $11.11) anchors the constructive side, but that same unanimity has been wrong for a year (-34.49% versus +10.03% for the S&P 500).
Supporting evidence cuts both ways. On the positive side: revenue of $4.895 billion in Q3 2026 versus $2.728 billion a year ago; gross margin of 28.19% versus 24.74% in Q2 and 14.17% in Q1; net loss narrowing to -$123 million from -$227.1 million in Q1; operating income marginally positive at $2 million; a current ratio of 3.58, debt-to-equity of 0.403, and $554 million of cash; and a forward PE of 26.48x against consensus EPS of $1.77, which is not demanding if that EPS materializes. On the negative side: trailing PE of -30.62x on EPS of -$0.024, EV/EBITDA of 51.55x versus mid-teens for mature distributors, PS of 1.73x and EV/Sales of 2.18x that are elevated for the sector, ROE of -2.88% and ROA of -0.21%, and a share count that rose from 716.5 million to 1.081 billion.
Three risks could invalidate the thesis: (1) TopBuild integration friction causing gross margin to retreat from 28.19%, which would leave the 51.55x EV/EBITDA multiple unsupported; (2) continued negative free cash flow forcing dilutive equity or expensive debt issuance, repeating the share-count expansion already seen; and (3) a housing-cycle downturn hitting the concentrated building-products revenue base ($3.929 billion of product sales versus $966 million of service revenue). The rating would upgrade to Buy on two consecutive quarters of positive free cash flow with gross margin sustained above 27%, or on a decisive break above the $13.50–$14.00 resistance zone on volume; it would downgrade to Sell on a close below the $10.04 52-week low or if consensus EPS of $1.77 is cut materially. Valuation verdict: the stock looks cheap on PS (1.73x, near the low end of its post-transformation range versus 8.36x in Q1 2026) but expensive on EV/EBITDA (51.55x) — it is fairly valued only if the earnings ramp arrives, and overvalued on current cash generation.
Sign up to view all
QXO 12-Month Price Forecast
The forward view is genuinely two-sided: the operational trajectory is improving fast (gross margin nearly doubling in two quarters, losses narrowing from -$227.1 million to -$123 million, operating income turning marginally positive), but the cash-flow and leverage profile is not yet consistent with the valuation. At $11.11 the stock sits 10.7% above its 52-week low and 59.8% below its high, with a 2.359 beta that makes realized outcomes far more volatile than the consensus implies. The 55% base case assumes integration proceeds unevenly and the stock grinds toward the $15.00 low target rather than the $23.00 average, because the burden of proof on free cash flow has not been met. I would upgrade to bullish on two consecutive quarters of positive FCF with gross margin above 27%, and downgrade to bearish on a close below $10.04 or a material cut to the $1.77 forward EPS consensus.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on QXO, Inc.'s 12-month outlook, with a consensus price target around $23.00 and implied upside of +122.4% versus the current price.
Average Target
$23.00
20 analysts
Implied Upside
+122.4%
vs. current price
Analyst Count
20
covering this stock
Price Range
$15 - $50
Analyst target range
Coverage is robust, with 18 analysts contributing to a consensus recommendation of "strong buy" (mean rating 1.3) and a distribution of 19 Buy, 1 Hold, and 0 Sell ratings. The average target price of $23.00 implies roughly +107% upside from the current $11.11, a gap that is unusually wide and signals a stark disconnect between sell-side conviction and market pricing. The consensus leans decisively bullish, and the recent institutional ratings flow — Wells Fargo reiterating Overweight twice in October 2026, Truist reiterating Buy, RBC reiterating Outperform, and Citigroup, KeyBanc, Stephens, and Baird all maintaining Buy/Overweight ratings through mid-2026 — shows analysts have held their ground rather than capitulating despite the stock's collapse.\n\nThe target range of $15.00 to $50.00 is extraordinarily wide — the high target is more than 3.3x the low — which signals very high uncertainty and low conviction in any single outcome. The $50 high target implicitly assumes successful TopBuild integration, rapid deleveraging, margin expansion toward distribution-sector norms, and a re-rating to a premium multiple on the ~$31 billion forward revenue base; the $15 low target (still +35% above the current price) prices in continued losses, integration friction, and multiple compression but stops short of a bear-case collapse. Notably, even the lowest analyst target sits above the current price, suggesting the sell-side views the recent selloff as overdone relative to fundamentals. The risk for investors is that this unanimity of bullishness has so far been wrong — the stock is down -34.49% over the past year against a +10.03% gain for the S&P 500, a -44.52 point relative-strength gap — and a wide target spread combined with a 2.36 beta means realized outcomes are likely to be far more volatile than the consensus implies.
Bulls vs Bears: QXO Investment Factors
The bear case currently has stronger near-term evidence: the stock is in a confirmed downtrend (-43.66% YTD, -62.54% max drawdown), free cash flow is negative, interest coverage is effectively nil at 0.012x, and the entire valuation depends on a forward EPS of $1.77 that has never been earned. The bull case rests on a genuine transformation — revenue up +79.42% YoY to $4.895 billion, gross margin climbing from 14.17% to 28.19% in two quarters, and a sell-side consensus of 19 Buy versus 0 Sell with a $23.00 average target — but that conviction has been wrong for a year. The single most important tension is whether the TopBuild integration converts scale into sustainable margin and free cash flow: if gross margins hold near 28% and SG&A leverage continues, the 51.55x EV/EBITDA compresses through earnings and the $23 target becomes reachable; if integration stalls, the premium multiple and the capital-markets-dependent model are both exposed. Until FCF turns positive, the market is treating the roll-up as value destruction rather than value creation, and the burden of proof sits with management.
Bullish
- Sell-side unanimity at extreme discount: 19 Buy ratings versus 1 Hold and 0 Sell, with a consensus mean of 1.3 (strong buy) and an average target of $23.00 implying +107% upside from $11.11. Even the lowest target of $15.00 sits +35% above the current price, meaning no analyst's published view prices in further downside from here.
- Revenue scale-up is real and rapid: Quarterly revenue reached $4.895 billion in Q3 2026, up +79.42% year-over-year from $2.728 billion, versus just $13.5 million in Q1 2025. Consensus forward revenue of ~$31.2 billion (range $28.9–$34.1 billion) confirms the platform has genuine scale in an ~$800 billion addressable market.
- Gross margin inflecting sharply upward: Gross margin rose to 28.19% in Q3 2026 from 24.74% in Q2 2026 and 14.17% in Q1 2026, lifting gross profit to $1.38 billion. If this trajectory holds, the 51.55x EV/EBITDA multiple compresses naturally through earnings growth rather than requiring a re-rating.
- Losses narrowing quarter over quarter: Net loss improved to -$123 million (EPS -$0.17, net margin -2.51%) from -$227.1 million in Q1 2026 (-13.13% margin) and -$55 million in Q2 2026. Operating income turned marginally positive at $2 million, the first sign of SG&A leverage on the enlarged base.
Bearish
- Falling knife near 52-week low: At $11.11 the stock is only 10.7% above its 52-week low of $10.04 and 59.8% below the $27.61 high, sitting at roughly 6% of its 52-week range. It is down -34.49% over one year versus a +10.03% S&P gain — a -44.52 point relative-strength gap — and fell -7.49% in the most recent session alone.
- Cash burn and negative free cash flow: Trailing free cash flow is -$97.8 million, with -$56 million burned in Q3 2026 on just $1 million of operating cash flow. The company also paid -$66 million of dividends against negative earnings (payout ratio -37.5%), compounding the cash drain.
- Interest coverage near zero: Interest expense of $163 million in Q3 2026 against $2 million of operating income yields an interest coverage ratio of roughly 0.012x. With $371 million of quarterly D&A, the business is not yet earning enough from operations to service its debt without relying on financing.
- Valuation rests on earnings that don't exist: Trailing PE is -30.62x on EPS of -$0.024, while forward PE of 26.48x assumes consensus EPS of $1.77 — a swing from loss to profit that has not been demonstrated. EV/EBITDA of 51.55x is far above typical mid-teens distribution multiples and can only be justified by a successful TopBuild integration.
QXO Technical Analysis
QXO is in a pronounced, sustained downtrend: the stock is down -34.49% over the past year and -43.66% year-to-date, with a maximum drawdown of -62.54% from its peak. At $11.11, the shares sit just 10.7% above the 52-week low of $10.04 and a staggering 59.8% below the 52-week high of $27.61 — effectively trading at roughly 6% of the 52-week range (where 0% = the low and 100% = the high). That positioning near the bottom of the range signals a falling-knife dynamic rather than a value opportunity, with sellers in control and no evidence yet of a durable base.\n\nShort-term momentum is diverging sharply from the longer-term trend. The stock is up +2.30% over the past month versus a -4.04% decline in the S&P 500, producing a relative strength of +6.34 points, yet it remains down -21.26% over three months and -34.76% over six months. This pattern — a modest one-month bounce inside a violent multi-quarter decline — is characteristic of a bear-market rally or mean-reversion bounce rather than a trend reversal, particularly given the -7.49% single-day drop on the most recent session that erased much of the recent gains. Volume of roughly 23.4 million shares on a $11.8 billion market cap indicates heavy, conviction-driven trading, and the elevated short ratio of 6.4 days suggests meaningful short interest that could amplify volatility in either direction.\n\nKey technical levels are well defined. Support sits at the 52-week low of $10.04, and a decisive breakdown below that level would signal capitulation and likely open further downside with no historical floor nearby; resistance is anchored at the $27.61 52-week high, with intermediate supply likely clustered around the $13.50–$14.00 area where the stock repeatedly failed in August and September. The beta of 2.359 is the critical risk-management input: QXO is roughly 136% more volatile than the market, meaning a 1% S&P move implies a ~2.36% QXO move, so position sizing should be scaled down accordingly and stop-losses set wider than for a market-beta name. Combined with the 6.4-day short ratio, this is a high-torque instrument where a breakout above $14 on volume would be the first credible sign of a trend change, while a close below $10.04 would confirm the downtrend's continuation.
Beta
2.36
2.36x market volatility
Max Drawdown
-62.5%
Largest decline past year
52-Week Range
$10-$28
Price range past year
Annual Return
-35.8%
Cumulative gain past year
| Period | QXO Return | S&P 500 |
|---|---|---|
| 1m | +0.3% | -9.7% |
| 3m | -24.9% | -9.9% |
| 6m | -38.0% | -7.5% |
| 1y | -35.8% | +4.7% |
| ytd | -47.6% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QXO Fundamental Analysis
Revenue is growing explosively but almost entirely through acquisition rather than organic expansion. Latest quarterly revenue was $4.895 billion, up +79.42% year-over-year, and the multi-quarter trajectory shows a dramatic step-up from $1.730 billion in Q1 2026 and $3.246 billion in Q2 2026, versus just $2.728 billion in the year-ago Q3 2025 and a mere $13.5 million in Q1 2025 before the platform's transformation. Product revenue of $3.929 billion and service revenue of $966 million in the latest quarter reflect the newly acquired scale, and consensus estimates revenue of roughly $31.2 billion (range $28.9–$34.1 billion) for the forward period. The critical caveat is that this growth is inorganic — driven by the TopBuild deal and prior acquisitions — so the investment case hinges entirely on integration execution and whether management can eventually generate organic growth and margin expansion from the enlarged base.\n\nProfitability remains elusive and margins are volatile. The latest quarter produced a net loss of -$123 million (EPS -$0.17) on a net margin of -2.51%, an improvement from the -$227.1 million loss in Q1 2026 (net margin -13.13%) and the -$55 million loss in Q2 2026 (-1.69%), but still a loss. Gross margin has been climbing — 28.19% in Q3 2026 versus 24.74% in Q2 2026 and 14.17% in Q1 2026 — reflecting a richer mix and acquisition accounting, though the trailing gross margin of 16.80% and operating margin of -0.83% show the business is barely at breakeven operationally. Interest expense of $163 million in the quarter and $371 million of D&A are the primary drags, and with an interest coverage ratio of just 0.012x, the company is not yet earning enough to comfortably service its debt from operations.\n\nThe balance sheet is liquid but cash-flow negative and heavily acquisition-funded. Debt-to-equity is a manageable 0.403 and the current ratio is a strong 3.58, with $554 million of cash at the end of Q3 2026, but trailing free cash flow is -$97.8 million and the latest quarter alone burned -$56 million of FCF on just $1 million of operating cash flow. The company spent $8.968 billion on acquisitions in Q3 2026 and raised $3.804 billion in net financing, while repaying $2.967 billion of debt — a capital-markets-dependent model that leaves little room for error. ROE of -2.88% and ROA of -0.21% confirm the platform is not yet generating returns on the capital deployed, and the -$66 million of dividends paid against negative earnings (payout ratio -37.5%) further strains the cash position.
Quarterly Revenue
$4.9B
2026-09
Revenue YoY Growth
+79.4%
YoY Comparison
Gross Margin
28.2%
Latest Quarter
Free Cash Flow
$-97800001.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QXO Overvalued?
Because trailing net income is negative (EPS -$0.024, trailing PE of -30.62x), the PE ratio is not a meaningful primary metric; I therefore lead with the price-to-sales ratio of 1.73x and the EV/Sales of 2.18x, which are the appropriate gauges for a loss-making, acquisition-driven roll-up. The forward PE of 26.48x against a trailing PE of -30.62x implies the market expects a dramatic swing to profitability — consensus forward EPS of $1.77 versus a current loss — and that gap is the single most important assumption embedded in the valuation. The PEG ratio of -0.065 is meaningless given negative earnings, and the EV/EBITDA of 51.55x is extremely rich for a distribution business, underscoring how much of the valuation rests on future earnings that do not yet exist.\n\nOn a peer basis, the 1.73x PS and 2.18x EV/Sales are elevated for industrial distribution, where mature peers typically trade at low-single-digit sales multiples and mid-teens EBITDA multiples; QXO's 51.55x EV/EBITDA is a steep premium that can only be justified by the expected EBITDA ramp from the TopBuild integration. The 1.22x price-to-book is the one metric that looks cheap, but that reflects a book value inflated by acquisition-related equity issuance rather than underlying earning power. The premium is a bet on management's ability to convert scale into margin — if gross margins hold near the 28% recent level and SG&A leverage improves, the multiple could compress naturally through earnings growth; if integration stalls, the premium is vulnerable.\n\nHistorically, QXO's valuation multiples have been wildly unstable because the company was a near-shell before its acquisition campaign: PS ranged from 452x in Q1 2025 to 2.58x in Q3 2026, and PE has swung from -13.9x to -60.3x across recent quarters as losses fluctuated. The current PS of 1.73x is near the low end of its post-transformation range (versus 4.08x in Q2 2026 and 8.36x in Q1 2026), which on one hand suggests the market has already de-rated the stock aggressively, but on the other reflects genuine fundamental deterioration — widening losses, negative FCF, and dilution — rather than a clean value opportunity. The market is pricing in substantial execution risk, and the historical band offers little comfort given how briefly the company has operated at its current scale.
PE
-30.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 13x~122x
vs. Industry Avg
29.2x
Industry PE ~29.2x*
EV/EBITDA
51.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are concentrated in cash generation and debt service. Trailing free cash flow is -$97.8 million, and Q3 2026 alone burned -$56 million of FCF on just $1 million of operating cash flow, while interest expense of $163 million against $2 million of operating income produces an interest coverage ratio of roughly 0.012x. The model is capital-markets-dependent — $8.968 billion of acquisitions funded by $3.804 billion of net financing and $2.967 billion of debt repayment in a single quarter — leaving little margin for error if financing conditions tighten. Revenue is also highly concentrated in building products distribution (product sales of $3.929 billion versus $966 million of service revenue) and in the newly acquired TopBuild assets, so integration friction or a housing-cycle downturn hits the core of the P&L directly. Dilution is a further drag: diluted shares rose from 716.5 million to 1.081 billion, and ROE of -2.88% shows the enlarged equity base is not yet earning a return.
Market and competitive risks center on multiple compression and volatility. At 51.55x EV/EBITDA and 2.18x EV/Sales, QXO trades at a steep premium to mature industrial distributors that typically command mid-teens EBITDA multiples and low-single-digit sales multiples; if the EBITDA ramp disappoints, the de-rating could be severe, as the PS multiple has already fallen from 8.36x in Q1 2026 to 1.73x today. The beta of 2.359 means QXO is roughly 136% more volatile than the market, so a 1% S&P decline implies a ~2.36% QXO move, and the 6.4-day short ratio adds fuel for sharp moves in either direction. Competitive pressure is real: recent coverage explicitly flags IBP as a potentially safer way to play the same theme, and larger, better-capitalized distributors can compete on price in a low-margin sector. Housing-market sensitivity and any regulatory scrutiny of further consolidation in an ~$800 billion industry add external risk to the roll-up thesis.
In a worst-case scenario, integration of TopBuild stalls, gross margin retreats from the 28.19% Q3 level, free cash flow stays negative, and the company is forced to raise equity or debt on unfavorable terms — triggering analyst capitulation from the current 19 Buy / 0 Sell consensus. The realistic downside is a retest of the 52-week low of $10.04, roughly -9.6% from $11.11, and a decisive break below that level would leave no historical floor nearby, with the -62.54% max drawdown illustrating how far this name can fall in a sustained de-rating. Applying that historical drawdown from the $27.61 high implies a trough near $10.34, consistent with the 52-week low, but a true bear case involving a failed integration and a dilutive rescue financing could plausibly take the stock toward the $8–9 range, or -20% to -28% from current levels. Position sizing should reflect the 2.359 beta and the fact that the lowest published analyst target of $15.00 has already proven unreliable as a floor.
FAQ
The most severe risk is financial: trailing free cash flow of -$97.8 million and interest coverage of roughly 0.012x mean the capital-markets-dependent model has almost no cushion if financing conditions tighten or integration slips. Second is dilution and integration risk — diluted shares already rose from 716.5 million to 1.081 billion, and a further equity raise to fund the $8.968 billion acquisition program would hit holders again. Third is valuation compression: at 51.55x EV/EBITDA, any disappointment in the EBITDA ramp could force a sharp de-rating, and the PS multiple has already collapsed from 8.36x to 1.73x. Fourth is macro and cyclical exposure — product sales of $3.929 billion versus $966 million of service revenue tie the P&L to housing demand, and a 2.359 beta means a 1% S&P decline implies roughly a 2.36% QXO move. Ranked by severity: cash flow/debt service first, dilution second, multiple compression third, housing-cycle sensitivity fourth.
The scenario framework assigns a 55% probability to the base case of $15.00–$23.00, a 25% probability to the bear case of $8.00–$10.04, and a 20% probability to the bull case of $23.00–$50.00. The base case is most likely: integration proceeds unevenly, gross margin oscillates in the mid-20s, free cash flow stays near breakeven, and the stock grinds from $11.11 toward the $15.00 low analyst target rather than the $23.00 average, with the higher end reachable only late in the window after two clean quarters. The bull case requires gross margin sustained above 27%, positive operating cash flow, and explicit deleveraging guidance; the bear case requires a stalled integration, a dilutive rescue financing, and analyst capitulation from the current 19 Buy / 0 Sell consensus. The key assumption behind the base case is that forward EPS of $1.77 is only partially achieved, landing nearer the $1.60 low estimate.
The answer differs sharply by metric, which is the heart of the debate. On sales, QXO looks cheap: PS of 1.73x is near the low end of its post-transformation range (versus 4.08x in Q2 2026 and 8.36x in Q1 2026), and price-to-book of 1.22x is modest. On earnings power, it looks expensive: EV/EBITDA of 51.55x is far above the mid-teens multiples typical of mature distributors, and the forward PE of 26.48x rests on consensus EPS of $1.77 that has never been earned against a trailing EPS of -$0.024. The market is therefore paying a premium for a future earnings ramp rather than current cash generation — it is fairly valued only if the TopBuild integration delivers margin and FCF, and overvalued on today's fundamentals. The aggressive de-rating from 8.36x to 1.73x PS suggests much execution risk is already priced in, but not all of it.
It depends entirely on your risk tolerance and time horizon, because the risk/reward is unusually asymmetric in both directions. The reward side is anchored by a 19 Buy / 1 Hold / 0 Sell consensus and a $23.00 average target, implying roughly +107% upside from $11.11, with even the lowest $15.00 target sitting +35% above the current price. The risk side is that trailing free cash flow is -$97.8 million, interest coverage is roughly 0.012x against $163 million of quarterly interest expense, and the stock is only 10.7% above its $10.04 52-week low after a -34.49% one-year decline versus a +10.03% S&P gain. For a patient, risk-tolerant investor who sizes the position for a 2.359 beta and accepts that the $1.77 forward EPS may arrive late, the setup is a speculative buy on weakness; for anyone needing capital preservation or near-term certainty, it is not a good buy until free cash flow turns positive.
QXO is structurally a long-term holding candidate but practically a high-volatility trading vehicle, so the honest answer is that it suits a multi-year horizon only for investors who can tolerate large interim drawdowns. The growth story — a roll-up targeting ~$50 billion in revenue within a decade from a ~$31.2 billion forward revenue base — is inherently multi-year, and the earnings visibility is poor: the company has posted net losses in every recent quarter, the forward EPS of $1.77 is unproven, and the 0.89% dividend yield is funded against negative earnings (payout ratio -37.5%). With a beta of 2.359, a -62.54% max drawdown, and a 6.4-day short ratio, short-term trading requires tight risk controls and wide stops around the $10.04 support and $13.50–$14.00 resistance. A reasonable minimum holding period is 18–24 months, long enough to see two to four quarters of FCF and integration evidence, and positions should be sized well below market-beta equivalents.

